<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02161276</url>
  </required_header>
  <id_info>
    <org_study_id>TNTL-14-01</org_study_id>
    <nct_id>NCT02161276</nct_id>
  </id_info>
  <brief_title>Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule</brief_title>
  <acronym>TNTL</acronym>
  <official_title>Phase 2 Study of The Optimal Dosage of Tang Ning Tongluo Capsule for Type II Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guizhou Bailing Group Pharmaceutical Co Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guizhou Bailing Group Pharmaceutical Co Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of diabetes mellitus with Traditional Chinese Medicine has a long history.

      aim： --establish the optimal dosage of traditional Chinese medicine Tang Ning Tongluo Capsule
      to treat type II diabetes mellitus.

      ---Preliminary evaluate the clinical efficacy and safety of Tangning Tongluo Capsule in the
      treatment of type II diabetes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preliminary evaluation on the clinical efficacy and safety of Tangning Tongluo Capsule in the
      treatment of type II diabetes, and provides basis for determining optimal dosage of Tangning
      Tongluo capsule.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The decline glycosylated hemoglobin A1C and blood glucose level</measure>
    <time_frame>up to 8 weeks</time_frame>
    <description>Decline in Hemoglobin A1C and blood glucose level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The clinical composite safety evaluation of Tangning Tongluo Capsule in the treatment of type II diabetes participants</measure>
    <time_frame>2 months</time_frame>
    <description>Routine check for blood, urine, stool + occult blood, liver function (ALT, AST, AKP, GGT, TBIL), renal function (BuN, Cr), ECG before treatment with 1 times per week.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Accidental Exposure While Preparing Drug for Administration</condition>
  <arm_group>
    <arm_group_label>TNTL capsule and Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3-4 capsules 3 times a day Used before meals</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TNTL capsule</intervention_name>
    <description>Patients were asked to taken drugs 3 times a day, with each time 3 grains</description>
    <arm_group_label>TNTL capsule and Placebo</arm_group_label>
    <other_name>Tang Ning Tongluo Capsule</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients were asked to taken drugs 3 times a day, with each time 3 grains</description>
    <arm_group_label>TNTL capsule and Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Fulfilled diagnostic criteria for type II diabetes and TCM syndrome diagnostic
             criteria.

          2. Age between 18-70 years.

          3. The blood sugar meet the following criteria: fasting blood glucose ≥ 7.0mmol/L, ≤ 13
             mmol/L and (or) ≥ 2 hour postprandial blood glucose 11.1 mmol/L, ≤ 16 mmol/L; eligible
             conditions in blood glucose, glycosylated hemoglobin to ≤ 10%.

          4. Traditional Chinese medicine symptom score ≥ 4 points.

          5. Participated in the experiment voluntarily, and signed the informed consent form.

        Exclusion Criteria:

          1. Durring the cleaning period, blood sugar dropped to below detection diagnosis value
             through diet, increasing activity.

          2. Secondary diabetes mellitus or nearly a month using insulin; or is the use of insulin
             sensitizers (thiazolidine two ketones), repaglinide, Bernard Glenn Nai, alpha
             glucoside enzyme inhibitor (acarbose, voglibose), other traditional Chinese medicine.

          3. Within the past 1 months, with diabetic ketoacidosis and other acute metabolic
             disorders.

          4. ALT is 2 times higher than the upper limit of the normal value, Cr is higher than the
             upper limit of normal persons.

          5. Has severe heart, liver, renal, hematopoietic system disease, or other serious
             diseases and mental disease patients.

          6. Pregnant, lactating women and prepare for pregnancy.

          7. The allergic constitution and the drug allergy known composition.

          8. For nearly a month with severe infection or other emergency state, such as trauma,
             operation etc..

          9. within the past 3 months, participated in the other drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XY Xin, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>ICMJE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tianyuan Hospital of Guiyang City</name>
      <address>
        <city>Guiyang</city>
        <state>Guizhou</state>
        <zip>550007</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2014</study_first_submitted>
  <study_first_submitted_qc>June 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2014</study_first_posted>
  <last_update_submitted>September 10, 2014</last_update_submitted>
  <last_update_submitted_qc>September 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

